Navigation Links
GeoVax Labs Reports 2012 First Quarter Financial Results
Date:5/15/2012

in a timely manner, GeoVax's vaccines will be safe for human use, GeoVax's vaccines will effectively prevent AIDS in humans, vaccines will receive regulatory approvals necessary to be licensed and marketed, GeoVax raises required capital to complete vaccine development, there is development of competitive products that may be more effective, less costly, or easier to use than GeoVax's products, GeoVax will be able to enter into favorable manufacturing and distribution agreements, and other factors, over which GeoVax has no control. GeoVax assumes no obligation to update these forward-looking statements, and does not intend to do so. More information about these factors is contained in GeoVax's filings with the Securities and Exchange Commission including those set forth at "Risk Factors" in GeoVax's Form 10-K.

Contact
The Investor Relations Group:
Erika Moran, Investor Relations
Janet Vasquez, Public Relations
(212) 825-3210

FINANCIAL TABLES FOLLOWGEOVAX LABS, INC.Condensed Consolidated Statements of Operations Information(amounts in thousands, except per share data)Three Months EndedMarch 31, 2012

2011RevenuesGrant Revenue$
854

$
893Operating expenses:Research and development1,072

838General and administrative513

6621,585

1,500Other income:Interest income1

11

1Net loss$
(730)

$
(606)Loss per common share$  (0.04)

$
(0.04) GEOVAX LABS, INC.Condensed Balance Sheet Information(amounts in thousands)March 31,

Dec. 31,2012

2011Assets:Cash and cash equivalents$
2,240

$
,168Other current assets393

250Total current assets2,633

1,418Property, net 158

176Other assets46

51Total assets$
2,837

$
,645Liabilities and stockholders' equityCurrent liabilities$
510

$
941Stockholders' equity2,327

704Total liabilities and stockho
'/>"/>

SOURCE GeoVax Labs, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. GeoVax Labs CEO Update Letter to Shareholders
2. GeoVax Labs First Patient Inoculated in Phase 1/2 Clinical Trial for HIV/AIDS Therapeutic Vaccine
3. GeoVax Phase 2a Clinical Trial Completes Enrollment
4. GeoVax $3.6 Million Award Increased to $4.4 Million by U.S. Government
5. GeoVax Labs, Inc. Announces Second Quarter Financial Results
6. GeoVax Labs HIV/AIDS Vaccine Development Leadership to be Highlighted During 2011 World Vaccine Congress
7. GeoVax Announces Publication of Phase 1 Clinical Trial in The Journal of Infectious Diseases
8. GeoVax Launches a Second Clinical Site to Test the Therapeutic Benefit of its HIV Vaccine
9. David A. Dodd Appointed Chairman of the Board of GeoVax Labs
10. GeoVax Announces Expansion of Phase 2a Human HIV/AIDS Vaccine Trial
11. GeoVax Awarded Federal Grant Under the Qualifying Therapeutic Discovery Project Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... 2015 OpportunityAnalyzer: Cushing,s Syndrome - Opportunity ... GlobalData estimates that the 2013 sales for the ... across the 6MM covered in this report. Pharmaceutical ... time, and financial resources in the CS field, ... (R&D) strategies. One notable example is the fact ...
(Date:5/27/2015)... May 27, 2015 ... has announced the addition of the  "2015 ... Market"  report to their offering. ... issues pertaining to the US NAT laboratory ... demographic, social and technological trends with significant ...
(Date:5/27/2015)... Research and Markets ( ... the  "US Cancer Vaccine Market Outlook 2020" ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , , ,Cancer vaccines ... categories of prophylactic (preventive) and therapeutic (treatment) ... both of these groups have been marketed ...
Breaking Medicine Technology:OpportunityAnalyzer: Cushing's Syndrome - Opportunity Analysis and Forecasts to 2018 2OpportunityAnalyzer: Cushing's Syndrome - Opportunity Analysis and Forecasts to 2018 3OpportunityAnalyzer: Cushing's Syndrome - Opportunity Analysis and Forecasts to 2018 4United States Nucleic Acid Testing Market Strategies 2015-2020 2US Cancer Vaccine Market Outlook 2020 2US Cancer Vaccine Market Outlook 2020 3
... - Termination of Parkinson,s Disease Clinical Development and Focus ... Neuropathic Pain and Epilepsy ... is a first-in-class,orally administered, highly selective non-competitive AMPA-type glutamate,receptor ... disease, neuropathic pain, epilepsy, multiple,sclerosis and migraine prophylaxis., ...
... Napo,Pharmaceuticals, Inc., (LSE: NAPL and NAPU) is pleased ... Phase 2 trial for CRO-ID,(crofelemer for the treatment ... Glenmark Pharmaceuticals Limited (BSE: Glenmark). The,primary endpoints of ... frequency and stool consistency; additional endpoints followed,include degree ...
Cached Medicine Technology:Status of the E2007 (perampanel) Development Program 2Status of the E2007 (perampanel) Development Program 3Status of the E2007 (perampanel) Development Program 4Napo Announces Successful Clinical Results in Phase 2 Study of Crofelemer in Acute Adult Infectious Diarrhea 2Napo Announces Successful Clinical Results in Phase 2 Study of Crofelemer in Acute Adult Infectious Diarrhea 3Napo Announces Successful Clinical Results in Phase 2 Study of Crofelemer in Acute Adult Infectious Diarrhea 4Napo Announces Successful Clinical Results in Phase 2 Study of Crofelemer in Acute Adult Infectious Diarrhea 5
(Date:5/28/2015)... The second episode of “Extreme Weight Loss” Season ... need to transform their lives. Josh (29 years old) is ... deal with the death of his father. Kelli (26 years ... MO, who went into depression after her playing career ended. ... featured in one episode of “Extreme Weight Loss” on TUESDAY, ...
(Date:5/27/2015)... NJ (PRWEB) May 28, 2015 Throughout the ... study site for research comparing the validity and reliability of ... Dr. Preeti Nair, P.T., Ph.D., Associate Professor in the Department ... investigator for the study. , The Shaw Gait Assessment is ... piece of equipment. The GaitRite is considered the gold ...
(Date:5/27/2015)... Thermage was the first to come out ... in 2007 coinciding with the release of NXT or CPT, ... Precision Aesthetics was the first practice in New York to ... produced results that had never been achieved before non-surgically. ... still considered by many as the leading skin tightening device. ...
(Date:5/27/2015)... Ticket Down is a reputable source of 2015 ... currently in the middle of their series against the Anaheim Ducks ... If the Blackhawks can win tonight at home, this will tie ... 30th at the Honda Center in Anaheim. , During the ... Western Conference as they won the Pacific Division by 8 points ...
(Date:5/27/2015)... Ticket Down is a reputable source for 2015 Cleveland Cavaliers ... during the 2014-15 NBA season and they delighted their fan base ... of 118-88. , For the Cavaliers, this is their ... lost to the San Antonio Spurs. Once Lebron James joined ... it to the NBA finals increased tenfold. The team had ...
Breaking Medicine News(10 mins):Health News:“Extreme Weight Loss”: Josh and Kelli’s Journeys Begin at the University of Colorado Anschutz Health and Wellness Center 2Health News:“Extreme Weight Loss”: Josh and Kelli’s Journeys Begin at the University of Colorado Anschutz Health and Wellness Center 3Health News:Push to Walk Partners with Seton Hall University for Study 2Health News:Non-Surgical Fat Reduction and Skin Tightening Procedures, Thermage and Exilis, Increase 200% at Precision Aesthetics in New York, April 2015 2Health News:Blackhawks vs. Ducks NHL Western Conference Finals Tickets: Ticket Down Slashes Ticket Prices on Chicago Blackhawks vs. Anaheim Ducks 2015 NHL Western Conference Finals 2Health News:Cavs NBA Finals Tickets: Ticket Down Slashes Ticket Prices on Cleveland Cavaliers 2015 NBA Finals Tickets at Quicken Loans Arena and Offers Valuable Promo Code 2
... could boost death risk, researchers say , , TUESDAY, ... men at high risk for cardiovascular disease, diabetes and ... the odds, according to new studies. , Some ... common with age, are linked to several health conditions. ...
... to the public, agency says , , TUESDAY, June 17 (HealthDay ... letters warning more than two dozen companies to stop selling ... The agency is also cautioning consumers not to buy or ... and creams, and are sold under various names on the ...
... Labs That Are Looking to Place Strategic Bets for the ... ... /Xinhua-PRNewswire/ -- Singapore,s investment of,more than US$2.1 billion in the biomedical sciences ... spending in the,biomedical sciences grew by more than 24% to reach US$760 ...
... Many Have Changed to Health Care & Economic Security ... SPRINGFIELD, Ill., June 17 150 years ago,this ... the,Illinois State Capitol in Springfield. AARP Illinois took the ... issues have changed,the problems of division preventing progress on ...
... Health,Insurance Plans (AHIP) today announced a new ... information technology company, to assist,health insurance plans ... consumers., "This partnership reflects our industry,s ... Health Records," said Charles,Stellar, Executive Vice President ...
... Health,Services, Inc. (Nasdaq: GTIV ), the nation,s leading ... is scheduled to,present from 1:00 to 1:30 p.m. ET, ... Conference in New York., The presentation will be ... which may be accessed by visiting, http://investors.gentiva.com/events.cfm to ...
Cached Medicine News:Health News:Studies Support Testosterone Supplements for Older Men 2Health News:FDA Warns Companies to Stop Selling Fake Cancer Cures 2Health News:FDA Warns Companies to Stop Selling Fake Cancer Cures 3Health News:Singapore Is One of the Fastest Growing Bioclusters in Asia; Wave of Investments in Drug Discovery and Translational Research 2Health News:Singapore Is One of the Fastest Growing Bioclusters in Asia; Wave of Investments in Drug Discovery and Translational Research 3Health News:Singapore Is One of the Fastest Growing Bioclusters in Asia; Wave of Investments in Drug Discovery and Translational Research 4Health News:Singapore Is One of the Fastest Growing Bioclusters in Asia; Wave of Investments in Drug Discovery and Translational Research 5Health News:Singapore Is One of the Fastest Growing Bioclusters in Asia; Wave of Investments in Drug Discovery and Translational Research 6Health News:150 Years Later 'House Divided' Speech Still Holds Strong Message 2Health News:AHIP Selects HealthTrio to Join AHIP Solutions Program 2Health News:Gentiva(R) Health Services to Present June 24 at Jefferies' 2nd Annual Healthcare Conference in New York 2Health News:Gentiva(R) Health Services to Present June 24 at Jefferies' 2nd Annual Healthcare Conference in New York 3
...
...
...
Tip is bent towards port for downward irrigation. 25G x 5/8in (.50 x 22mm)...
Medicine Products: